Comparative effectiveness of intensity modulated radiation therapy to 3-dimensional conformal radiation in locally advanced lung cancer: pathological and clinical outcomes
Authors:
- 1 April 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 92 (1097) , 20180960
Abstract
Objective: Intensity-modulated radiotherapy (IMRT) has better normal-tissue sparing compared with 3-dimensional conformal radiation (3DCRT). We sought to assess the impact of radiation technique on pathological and clinical outcomes in locally advanced non-small cell lung cancer (LANSCLC) treated with a trimodality strategy. Methods: Retrospective review of LANSCLC patients treated from August 2012 to August 2018 at Sheba Medical Center, Israel. The trimodality strategy consisted of concomitant chemoradiation to 60 Gray (Gy) followed by completion surgery. The planning target volume (PTV) was defined by co-registered PET/CT. Here we compare the pathological regression, surgical margin status, local control rates (LC), disease free (DFS) and overall survival (OS) between 3DCRT and IMRT. Results: Our cohort consisted of 74 patients with mean age 62.9 years, male in 51/74 (69%), adenocarcinoma in 46/74 (62.1%), stage 3 in 59/74 (79.7%) and chemotherapy in 72/74 (97.3%). Radiation mean dose: 59.2 Gy (SD ± 3.8). Radiation technique : 3DCRT in 51/74 (68.9%), IMRT in 23/74 (31%). Other variables were similar between groups.Major pathological response (including pathological complete response or less than 10% residual tumor cells) was similar: 32/51 (62.7%) in 3DCRT and 15/23 (65.2%) in IMRT, p=0.83. Pathological complete response (pCR) rates were similar: 17/51 (33.3%) in 3DCRT and 8/23 (34.8%) in IMRT, p=0.9. Surgical margins were negative in 46/51 (90.1%) in 3DCRT vs. 17/19 (89.4%) in IMRT (p=1.0).The 2-year LC rates were 81.6% (95% CI 69-89.4%); DFS 58.3% (95% CI 45.5-69%) and 3-year OS 70% (95% CI57-80%). Comparing radiation techniques, there were no significant differences in LC (p=0.94), DFS (p=0.33) and OS (p=0.72). Conclusion: When used to treat LANSCLC in the neoadjuvant setting, both IMRT and 3DCRT produce comparable pathological and clinical outcomes. Advances in knowledge: This study validates the real-world effectiveness of IMRT compared to 3DCRT.Keywords
This publication has 18 references indexed in Scilit:
- Quality of Life (QOL) Analysis of the Randomized Radiation (RT) Dose-Escalation NSCLC Trial (RTOG 0617): The Rest of the StoryInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- Comparison of 2 Common Radiation Therapy Techniques for Definitive Treatment of Small Cell Lung CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- Radiation Therapy Oncology Group Protocol 02-29: A Phase II Trial of Neoadjuvant Therapy With Concurrent Chemotherapy and Full-Dose Radiation Therapy Followed by Surgical Resection and Consolidative Therapy for Locally Advanced Non-small Cell Carcinoma of the LungInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Histopathologic Response Criteria Predict Survival of Patients with Resected Lung Cancer After Neoadjuvant ChemotherapyJournal of Thoracic Oncology, 2012
- Use of a realistic breathing lung phantom to evaluate dose delivery errorsa)Medical Physics, 2010
- Cone-Beam Computed Tomographic Image Guidance for Lung Cancer Radiation TherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Initial Evaluation of Treatment-Related Pneumonitis in Advanced-Stage Non–Small-Cell Lung Cancer Patients Treated With Concurrent Chemotherapy and Intensity-Modulated RadiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Impact of geometrical uncertainties on 3D CRT and IMRT dose distributions for lung cancer treatmentInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non–small-cell lung cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Grading of Tumor Regression in Non-small Cell Lung CancerChest, 2001